Stocktoria

Longeveron Inc. LGVN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2021-02-12

Longeveron Inc. statistics & valuation

Market cap$22.6M
P / S18.9×
P / B4.0×
Net margin-1893.6%
FCF margin-1575.5%
Return on capital-377.2%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-66.10% -1305.10% -1541.30% -3020.20% -667.80% -1893.60% 202020212022202320242025
Gross margin (%)
32.40% 45.20% 40.70% 31.20% 78.80% 67.00% 202020212022202320242025
Operating margin (%)
-67.10% -1336.60% -1476.50% -2966.00% -690.70% -1942.20% 202020212022202320242025
Return on equity (%)
-190.10% -45.50% -91.90% -317.70% -73.00% -400.10% 202020212022202320242025
Shares outstanding
18.9M 21.0M 2.17B 9.41B 17.58B 202020212022202320242025
Net debt ($)
-$505000 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-40.30% -39.90% -68.70% -177.30% -62.50% -221.30% 202020212022202320242025
Free cash flow margin (%)
-44.30% -763.10% -1189.70% -2722.60% -607.10% -1575.50% 202020212022202320242025
Debt / equity (×)
0.16× 202020212022202320242025
EPS ($)
-$0.90 -$0.90 -$10.22 -$2.62 -$1.29 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin67.0%78.8%31.2%40.7%45.2%32.4%
Operating margin-1942.2%-690.7%-2966.0%-1476.5%-1336.6%-67.1%
Net margin-1893.6%-667.8%-3020.2%-1541.3%-1305.1%-66.1%
FCF margin-1575.5%-607.1%-2722.6%-1189.7%-763.1%-44.3%
Return on assets-221.3%-62.5%-177.3%-68.7%-39.9%-40.3%
Return on equity-400.1%-73.0%-317.7%-91.9%-45.5%-190.1%
Debt / equity—————0.16×
Current ratio1.337.601.504.1713.060.48

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.